nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadofosveset trisodium—ALB—Irinotecan—colon cancer	0.291	0.402	CbGbCtD
Gadofosveset trisodium—ALB—Fluorouracil—colon cancer	0.279	0.386	CbGbCtD
Gadofosveset trisodium—ALB—Methotrexate—colon cancer	0.154	0.213	CbGbCtD
Gadofosveset trisodium—Visual impairment—Irinotecan—colon cancer	0.000859	0.00311	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Vincristine—colon cancer	0.00085	0.00308	CcSEcCtD
Gadofosveset trisodium—Hypoaesthesia—Fluorouracil—colon cancer	0.00085	0.00308	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Irinotecan—colon cancer	0.000827	0.003	CcSEcCtD
Gadofosveset trisodium—Flushing—Irinotecan—colon cancer	0.000827	0.003	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Vincristine—colon cancer	0.000825	0.00299	CcSEcCtD
Gadofosveset trisodium—Irritability—Capecitabine—colon cancer	0.000823	0.00298	CcSEcCtD
Gadofosveset trisodium—Blood creatinine increased—Capecitabine—colon cancer	0.000808	0.00293	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Irinotecan—colon cancer	0.000805	0.00292	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Irinotecan—colon cancer	0.000804	0.00291	CcSEcCtD
Gadofosveset trisodium—Dehydration—Capecitabine—colon cancer	0.000802	0.00291	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Vincristine—colon cancer	0.000802	0.00291	CcSEcCtD
Gadofosveset trisodium—Chills—Irinotecan—colon cancer	0.0008	0.0029	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Irinotecan—colon cancer	0.000796	0.00289	CcSEcCtD
Gadofosveset trisodium—Hypokalaemia—Capecitabine—colon cancer	0.000785	0.00285	CcSEcCtD
Gadofosveset trisodium—Breast disorder—Capecitabine—colon cancer	0.000779	0.00283	CcSEcCtD
Gadofosveset trisodium—Nasopharyngitis—Capecitabine—colon cancer	0.000771	0.0028	CcSEcCtD
Gadofosveset trisodium—Sepsis—Methotrexate—colon cancer	0.000768	0.00278	CcSEcCtD
Gadofosveset trisodium—Flatulence—Irinotecan—colon cancer	0.000765	0.00277	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Fluorouracil—colon cancer	0.000763	0.00277	CcSEcCtD
Gadofosveset trisodium—Abdominal distension—Capecitabine—colon cancer	0.00075	0.00272	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Irinotecan—colon cancer	0.000746	0.0027	CcSEcCtD
Gadofosveset trisodium—Dysphagia—Capecitabine—colon cancer	0.000745	0.0027	CcSEcCtD
Gadofosveset trisodium—Erythema—Fluorouracil—colon cancer	0.000743	0.00269	CcSEcCtD
Gadofosveset trisodium—Bronchospasm—Capecitabine—colon cancer	0.000733	0.00266	CcSEcCtD
Gadofosveset trisodium—Sweating increased—Capecitabine—colon cancer	0.000726	0.00263	CcSEcCtD
Gadofosveset trisodium—Bronchitis—Capecitabine—colon cancer	0.000717	0.0026	CcSEcCtD
Gadofosveset trisodium—Vertigo—Vincristine—colon cancer	0.000716	0.0026	CcSEcCtD
Gadofosveset trisodium—Abdominal discomfort—Capecitabine—colon cancer	0.000715	0.00259	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Fluorouracil—colon cancer	0.000701	0.00254	CcSEcCtD
Gadofosveset trisodium—Vertigo—Irinotecan—colon cancer	0.000697	0.00253	CcSEcCtD
Gadofosveset trisodium—Syncope—Irinotecan—colon cancer	0.000696	0.00252	CcSEcCtD
Gadofosveset trisodium—Renal failure acute—Methotrexate—colon cancer	0.000695	0.00252	CcSEcCtD
Gadofosveset trisodium—Convulsion—Vincristine—colon cancer	0.00069	0.0025	CcSEcCtD
Gadofosveset trisodium—Hypertension—Vincristine—colon cancer	0.000688	0.00249	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Irinotecan—colon cancer	0.000682	0.00247	CcSEcCtD
Gadofosveset trisodium—Cough—Irinotecan—colon cancer	0.000677	0.00245	CcSEcCtD
Gadofosveset trisodium—Hyperglycaemia—Capecitabine—colon cancer	0.000672	0.00244	CcSEcCtD
Gadofosveset trisodium—Hypertension—Irinotecan—colon cancer	0.00067	0.00243	CcSEcCtD
Gadofosveset trisodium—Infestation NOS—Capecitabine—colon cancer	0.000665	0.00241	CcSEcCtD
Gadofosveset trisodium—Infestation—Capecitabine—colon cancer	0.000665	0.00241	CcSEcCtD
Gadofosveset trisodium—Anaphylactoid reaction—Methotrexate—colon cancer	0.000663	0.0024	CcSEcCtD
Gadofosveset trisodium—Acute coronary syndrome—Capecitabine—colon cancer	0.000655	0.00238	CcSEcCtD
Gadofosveset trisodium—Cerebrovascular accident—Methotrexate—colon cancer	0.000655	0.00238	CcSEcCtD
Gadofosveset trisodium—Renal failure—Capecitabine—colon cancer	0.000653	0.00237	CcSEcCtD
Gadofosveset trisodium—Myocardial infarction—Capecitabine—colon cancer	0.000652	0.00236	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Vincristine—colon cancer	0.00065	0.00236	CcSEcCtD
Gadofosveset trisodium—Oedema—Vincristine—colon cancer	0.00065	0.00236	CcSEcCtD
Gadofosveset trisodium—Infection—Vincristine—colon cancer	0.000646	0.00234	CcSEcCtD
Gadofosveset trisodium—Urinary tract infection—Capecitabine—colon cancer	0.000646	0.00234	CcSEcCtD
Gadofosveset trisodium—Convulsion—Fluorouracil—colon cancer	0.000644	0.00233	CcSEcCtD
Gadofosveset trisodium—Confusional state—Irinotecan—colon cancer	0.000639	0.00232	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Vincristine—colon cancer	0.000638	0.00231	CcSEcCtD
Gadofosveset trisodium—Haematuria—Capecitabine—colon cancer	0.000634	0.0023	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Irinotecan—colon cancer	0.000633	0.0023	CcSEcCtD
Gadofosveset trisodium—Oedema—Irinotecan—colon cancer	0.000633	0.0023	CcSEcCtD
Gadofosveset trisodium—Chest pain—Fluorouracil—colon cancer	0.000633	0.00229	CcSEcCtD
Gadofosveset trisodium—Infection—Irinotecan—colon cancer	0.000629	0.00228	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Vincristine—colon cancer	0.000629	0.00228	CcSEcCtD
Gadofosveset trisodium—Shock—Irinotecan—colon cancer	0.000623	0.00226	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Irinotecan—colon cancer	0.000621	0.00225	CcSEcCtD
Gadofosveset trisodium—Anorexia—Vincristine—colon cancer	0.00062	0.00225	CcSEcCtD
Gadofosveset trisodium—Irritability—Methotrexate—colon cancer	0.000613	0.00222	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Irinotecan—colon cancer	0.000612	0.00222	CcSEcCtD
Gadofosveset trisodium—Confusional state—Fluorouracil—colon cancer	0.000612	0.00222	CcSEcCtD
Gadofosveset trisodium—Hypotension—Vincristine—colon cancer	0.000608	0.0022	CcSEcCtD
Gadofosveset trisodium—Bradycardia—Capecitabine—colon cancer	0.000607	0.0022	CcSEcCtD
Gadofosveset trisodium—Oedema—Fluorouracil—colon cancer	0.000607	0.0022	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Fluorouracil—colon cancer	0.000607	0.0022	CcSEcCtD
Gadofosveset trisodium—Anorexia—Irinotecan—colon cancer	0.000604	0.00219	CcSEcCtD
Gadofosveset trisodium—Infection—Fluorouracil—colon cancer	0.000603	0.00218	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Fluorouracil—colon cancer	0.000595	0.00216	CcSEcCtD
Gadofosveset trisodium—Hypoaesthesia—Capecitabine—colon cancer	0.000594	0.00215	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Fluorouracil—colon cancer	0.000592	0.00215	CcSEcCtD
Gadofosveset trisodium—Hypotension—Irinotecan—colon cancer	0.000592	0.00215	CcSEcCtD
Gadofosveset trisodium—Urinary tract disorder—Capecitabine—colon cancer	0.000589	0.00214	CcSEcCtD
Gadofosveset trisodium—Connective tissue disorder—Capecitabine—colon cancer	0.000586	0.00213	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Capecitabine—colon cancer	0.000585	0.00212	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Vincristine—colon cancer	0.000584	0.00212	CcSEcCtD
Gadofosveset trisodium—Breast disorder—Methotrexate—colon cancer	0.00058	0.0021	CcSEcCtD
Gadofosveset trisodium—Anorexia—Fluorouracil—colon cancer	0.000578	0.0021	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Capecitabine—colon cancer	0.000575	0.00208	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Irinotecan—colon cancer	0.000569	0.00206	CcSEcCtD
Gadofosveset trisodium—Hypotension—Fluorouracil—colon cancer	0.000567	0.00205	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Vincristine—colon cancer	0.000565	0.00205	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Irinotecan—colon cancer	0.000565	0.00205	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Vincristine—colon cancer	0.000562	0.00204	CcSEcCtD
Gadofosveset trisodium—Fatigue—Vincristine—colon cancer	0.000561	0.00203	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Capecitabine—colon cancer	0.000558	0.00202	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Irinotecan—colon cancer	0.000558	0.00202	CcSEcCtD
Gadofosveset trisodium—Constipation—Vincristine—colon cancer	0.000556	0.00202	CcSEcCtD
Gadofosveset trisodium—Pain—Vincristine—colon cancer	0.000556	0.00202	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Capecitabine—colon cancer	0.000554	0.00201	CcSEcCtD
Gadofosveset trisodium—Flushing—Capecitabine—colon cancer	0.000554	0.00201	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Irinotecan—colon cancer	0.000551	0.002	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Irinotecan—colon cancer	0.000547	0.00198	CcSEcCtD
Gadofosveset trisodium—Fatigue—Irinotecan—colon cancer	0.000546	0.00198	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Fluorouracil—colon cancer	0.000545	0.00197	CcSEcCtD
Gadofosveset trisodium—Pain—Irinotecan—colon cancer	0.000542	0.00196	CcSEcCtD
Gadofosveset trisodium—Constipation—Irinotecan—colon cancer	0.000542	0.00196	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Fluorouracil—colon cancer	0.000541	0.00196	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Capecitabine—colon cancer	0.000539	0.00195	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Capecitabine—colon cancer	0.000538	0.00195	CcSEcCtD
Gadofosveset trisodium—Chills—Capecitabine—colon cancer	0.000535	0.00194	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Fluorouracil—colon cancer	0.000534	0.00194	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Capecitabine—colon cancer	0.000533	0.00193	CcSEcCtD
Gadofosveset trisodium—Abdominal discomfort—Methotrexate—colon cancer	0.000532	0.00193	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Vincristine—colon cancer	0.000532	0.00193	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Fluorouracil—colon cancer	0.000527	0.00191	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000524	0.0019	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Capecitabine—colon cancer	0.000523	0.00189	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Irinotecan—colon cancer	0.000522	0.00189	CcSEcCtD
Gadofosveset trisodium—Erythema—Capecitabine—colon cancer	0.000519	0.00188	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Capecitabine—colon cancer	0.000519	0.00188	CcSEcCtD
Gadofosveset trisodium—Pain—Fluorouracil—colon cancer	0.000519	0.00188	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Irinotecan—colon cancer	0.000518	0.00188	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Vincristine—colon cancer	0.000514	0.00186	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Vincristine—colon cancer	0.000514	0.00186	CcSEcCtD
Gadofosveset trisodium—Flatulence—Capecitabine—colon cancer	0.000512	0.00186	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Capecitabine—colon cancer	0.000509	0.00184	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Irinotecan—colon cancer	0.000501	0.00182	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Irinotecan—colon cancer	0.000501	0.00182	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Fluorouracil—colon cancer	0.0005	0.00181	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Capecitabine—colon cancer	0.000499	0.00181	CcSEcCtD
Gadofosveset trisodium—Infestation NOS—Methotrexate—colon cancer	0.000495	0.00179	CcSEcCtD
Gadofosveset trisodium—Infestation—Methotrexate—colon cancer	0.000495	0.00179	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Capecitabine—colon cancer	0.00049	0.00177	CcSEcCtD
Gadofosveset trisodium—Tremor—Capecitabine—colon cancer	0.000487	0.00176	CcSEcCtD
Gadofosveset trisodium—Renal failure—Methotrexate—colon cancer	0.000486	0.00176	CcSEcCtD
Gadofosveset trisodium—Urticaria—Fluorouracil—colon cancer	0.000482	0.00175	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Fluorouracil—colon cancer	0.00048	0.00174	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Vincristine—colon cancer	0.000479	0.00174	CcSEcCtD
Gadofosveset trisodium—Haematuria—Methotrexate—colon cancer	0.000472	0.00171	CcSEcCtD
Gadofosveset trisodium—Vertigo—Capecitabine—colon cancer	0.000467	0.00169	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Irinotecan—colon cancer	0.000467	0.00169	CcSEcCtD
Gadofosveset trisodium—Asthenia—Vincristine—colon cancer	0.000467	0.00169	CcSEcCtD
Gadofosveset trisodium—Syncope—Capecitabine—colon cancer	0.000466	0.00169	CcSEcCtD
Gadofosveset trisodium—Palpitations—Capecitabine—colon cancer	0.000459	0.00166	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Capecitabine—colon cancer	0.000457	0.00165	CcSEcCtD
Gadofosveset trisodium—Asthenia—Irinotecan—colon cancer	0.000454	0.00165	CcSEcCtD
Gadofosveset trisodium—Cough—Capecitabine—colon cancer	0.000453	0.00164	CcSEcCtD
Gadofosveset trisodium—Hypertension—Capecitabine—colon cancer	0.000448	0.00163	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Fluorouracil—colon cancer	0.000447	0.00162	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Vincristine—colon cancer	0.000445	0.00161	CcSEcCtD
Gadofosveset trisodium—Chest pain—Capecitabine—colon cancer	0.000442	0.0016	CcSEcCtD
Gadofosveset trisodium—Anxiety—Capecitabine—colon cancer	0.000441	0.0016	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000439	0.00159	CcSEcCtD
Gadofosveset trisodium—Urinary tract disorder—Methotrexate—colon cancer	0.000439	0.00159	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Methotrexate—colon cancer	0.000435	0.00158	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Irinotecan—colon cancer	0.000433	0.00157	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Capecitabine—colon cancer	0.000432	0.00157	CcSEcCtD
Gadofosveset trisodium—Dizziness—Vincristine—colon cancer	0.00043	0.00156	CcSEcCtD
Gadofosveset trisodium—Pruritus—Fluorouracil—colon cancer	0.000429	0.00156	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Methotrexate—colon cancer	0.000428	0.00155	CcSEcCtD
Gadofosveset trisodium—Confusional state—Capecitabine—colon cancer	0.000427	0.00155	CcSEcCtD
Gadofosveset trisodium—Oedema—Capecitabine—colon cancer	0.000424	0.00154	CcSEcCtD
Gadofosveset trisodium—Infection—Capecitabine—colon cancer	0.000421	0.00153	CcSEcCtD
Gadofosveset trisodium—Dizziness—Irinotecan—colon cancer	0.000419	0.00152	CcSEcCtD
Gadofosveset trisodium—Shock—Capecitabine—colon cancer	0.000417	0.00151	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Capecitabine—colon cancer	0.000416	0.00151	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Methotrexate—colon cancer	0.000415	0.0015	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Fluorouracil—colon cancer	0.000415	0.0015	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Capecitabine—colon cancer	0.000414	0.0015	CcSEcCtD
Gadofosveset trisodium—Vomiting—Vincristine—colon cancer	0.000414	0.0015	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Methotrexate—colon cancer	0.000412	0.00149	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Capecitabine—colon cancer	0.000412	0.00149	CcSEcCtD
Gadofosveset trisodium—Rash—Vincristine—colon cancer	0.00041	0.00149	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Capecitabine—colon cancer	0.00041	0.00149	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Vincristine—colon cancer	0.00041	0.00149	CcSEcCtD
Gadofosveset trisodium—Headache—Vincristine—colon cancer	0.000407	0.00148	CcSEcCtD
Gadofosveset trisodium—Anorexia—Capecitabine—colon cancer	0.000404	0.00146	CcSEcCtD
Gadofosveset trisodium—Vomiting—Irinotecan—colon cancer	0.000403	0.00146	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Methotrexate—colon cancer	0.000401	0.00145	CcSEcCtD
Gadofosveset trisodium—Dizziness—Fluorouracil—colon cancer	0.000401	0.00145	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Methotrexate—colon cancer	0.0004	0.00145	CcSEcCtD
Gadofosveset trisodium—Rash—Irinotecan—colon cancer	0.000399	0.00145	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Irinotecan—colon cancer	0.000399	0.00145	CcSEcCtD
Gadofosveset trisodium—Chills—Methotrexate—colon cancer	0.000399	0.00144	CcSEcCtD
Gadofosveset trisodium—Headache—Irinotecan—colon cancer	0.000397	0.00144	CcSEcCtD
Gadofosveset trisodium—Hypotension—Capecitabine—colon cancer	0.000396	0.00144	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Methotrexate—colon cancer	0.000389	0.00141	CcSEcCtD
Gadofosveset trisodium—Erythema—Methotrexate—colon cancer	0.000387	0.0014	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Methotrexate—colon cancer	0.000387	0.0014	CcSEcCtD
Gadofosveset trisodium—Nausea—Vincristine—colon cancer	0.000386	0.0014	CcSEcCtD
Gadofosveset trisodium—Vomiting—Fluorouracil—colon cancer	0.000386	0.0014	CcSEcCtD
Gadofosveset trisodium—Rash—Fluorouracil—colon cancer	0.000383	0.00139	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Fluorouracil—colon cancer	0.000382	0.00139	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Capecitabine—colon cancer	0.000381	0.00138	CcSEcCtD
Gadofosveset trisodium—Headache—Fluorouracil—colon cancer	0.00038	0.00138	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Methotrexate—colon cancer	0.000379	0.00137	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Capecitabine—colon cancer	0.000378	0.00137	CcSEcCtD
Gadofosveset trisodium—Nausea—Irinotecan—colon cancer	0.000376	0.00136	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Capecitabine—colon cancer	0.000373	0.00135	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Capecitabine—colon cancer	0.000369	0.00134	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Capecitabine—colon cancer	0.000366	0.00133	CcSEcCtD
Gadofosveset trisodium—Fatigue—Capecitabine—colon cancer	0.000365	0.00132	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Methotrexate—colon cancer	0.000364	0.00132	CcSEcCtD
Gadofosveset trisodium—Pain—Capecitabine—colon cancer	0.000363	0.00131	CcSEcCtD
Gadofosveset trisodium—Constipation—Capecitabine—colon cancer	0.000363	0.00131	CcSEcCtD
Gadofosveset trisodium—Nausea—Fluorouracil—colon cancer	0.00036	0.00131	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Capecitabine—colon cancer	0.000349	0.00127	CcSEcCtD
Gadofosveset trisodium—Vertigo—Methotrexate—colon cancer	0.000347	0.00126	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Capecitabine—colon cancer	0.000347	0.00126	CcSEcCtD
Gadofosveset trisodium—Cough—Methotrexate—colon cancer	0.000337	0.00122	CcSEcCtD
Gadofosveset trisodium—Urticaria—Capecitabine—colon cancer	0.000337	0.00122	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Capecitabine—colon cancer	0.000335	0.00121	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Capecitabine—colon cancer	0.000335	0.00121	CcSEcCtD
Gadofosveset trisodium—Convulsion—Methotrexate—colon cancer	0.000335	0.00121	CcSEcCtD
Gadofosveset trisodium—Chest pain—Methotrexate—colon cancer	0.000329	0.00119	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000327	0.00119	CcSEcCtD
Gadofosveset trisodium—Confusional state—Methotrexate—colon cancer	0.000318	0.00115	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Methotrexate—colon cancer	0.000316	0.00114	CcSEcCtD
Gadofosveset trisodium—Infection—Methotrexate—colon cancer	0.000314	0.00114	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Capecitabine—colon cancer	0.000312	0.00113	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Methotrexate—colon cancer	0.000309	0.00112	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Methotrexate—colon cancer	0.000307	0.00111	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Methotrexate—colon cancer	0.000305	0.00111	CcSEcCtD
Gadofosveset trisodium—Asthenia—Capecitabine—colon cancer	0.000304	0.0011	CcSEcCtD
Gadofosveset trisodium—Anorexia—Methotrexate—colon cancer	0.000301	0.00109	CcSEcCtD
Gadofosveset trisodium—Pruritus—Capecitabine—colon cancer	0.0003	0.00109	CcSEcCtD
Gadofosveset trisodium—Hypotension—Methotrexate—colon cancer	0.000295	0.00107	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Capecitabine—colon cancer	0.00029	0.00105	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Methotrexate—colon cancer	0.000283	0.00103	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Methotrexate—colon cancer	0.000281	0.00102	CcSEcCtD
Gadofosveset trisodium—Dizziness—Capecitabine—colon cancer	0.00028	0.00102	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Methotrexate—colon cancer	0.000278	0.00101	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Methotrexate—colon cancer	0.000274	0.000994	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Methotrexate—colon cancer	0.000272	0.000988	CcSEcCtD
Gadofosveset trisodium—Fatigue—Methotrexate—colon cancer	0.000272	0.000986	CcSEcCtD
Gadofosveset trisodium—Pain—Methotrexate—colon cancer	0.00027	0.000978	CcSEcCtD
Gadofosveset trisodium—Vomiting—Capecitabine—colon cancer	0.00027	0.000977	CcSEcCtD
Gadofosveset trisodium—Rash—Capecitabine—colon cancer	0.000267	0.000969	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Capecitabine—colon cancer	0.000267	0.000968	CcSEcCtD
Gadofosveset trisodium—Headache—Capecitabine—colon cancer	0.000266	0.000963	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Methotrexate—colon cancer	0.00026	0.000943	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Methotrexate—colon cancer	0.000258	0.000935	CcSEcCtD
Gadofosveset trisodium—Nausea—Capecitabine—colon cancer	0.000252	0.000913	CcSEcCtD
Gadofosveset trisodium—Urticaria—Methotrexate—colon cancer	0.000251	0.000909	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Methotrexate—colon cancer	0.000249	0.000904	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Methotrexate—colon cancer	0.000249	0.000904	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Methotrexate—colon cancer	0.000233	0.000843	CcSEcCtD
Gadofosveset trisodium—Asthenia—Methotrexate—colon cancer	0.000226	0.000821	CcSEcCtD
Gadofosveset trisodium—Pruritus—Methotrexate—colon cancer	0.000223	0.000809	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Methotrexate—colon cancer	0.000216	0.000783	CcSEcCtD
Gadofosveset trisodium—Dizziness—Methotrexate—colon cancer	0.000209	0.000756	CcSEcCtD
Gadofosveset trisodium—Vomiting—Methotrexate—colon cancer	0.000201	0.000727	CcSEcCtD
Gadofosveset trisodium—Rash—Methotrexate—colon cancer	0.000199	0.000721	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Methotrexate—colon cancer	0.000199	0.000721	CcSEcCtD
Gadofosveset trisodium—Headache—Methotrexate—colon cancer	0.000198	0.000717	CcSEcCtD
Gadofosveset trisodium—Nausea—Methotrexate—colon cancer	0.000187	0.000679	CcSEcCtD
